C3.ai [AI] vs Amdocs [DOX] Detailed Stock Comparison

C3.ai

NYSE
Loading...

Amdocs

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: C3.ai wins in 5 metrics, Amdocs wins in 13 metrics, with 0 ties. Amdocs appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricC3.aiAmdocsBetter
P/E Ratio (TTM)-11.6116.66C3.ai
Price-to-Book Ratio4.152.58Amdocs
Debt-to-Equity Ratio7.1923.65C3.ai
PEG Ratio-76.471.20C3.ai
EV/EBITDA-9.019.66C3.ai
Profit Margin (TTM)-74.21%11.94%Amdocs
Operating Margin (TTM)-81.83%17.69%Amdocs
EBITDA Margin (TTM)N/A17.69%N/A
Return on Equity-33.73%15.73%Amdocs
Return on Assets (TTM)-19.65%7.87%Amdocs
Free Cash Flow (TTM)$-44.45M$618.93MAmdocs
1-Year Return-27.83%-6.59%Amdocs
Price-to-Sales Ratio (TTM)8.981.95Amdocs
Enterprise Value$2.81B$9.59BAmdocs
EV/Revenue Ratio7.232.06Amdocs
Gross Profit Margin (TTM)62.09%37.86%C3.ai
Revenue per Share (TTM)$3$41Amdocs
Earnings per Share (Diluted)$-2.24$4.94Amdocs
Beta (Stock Volatility)1.980.52Amdocs
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

C3.ai vs Amdocs Stock Performance Analysis

Loading Price Chart...

C3.ai
Amdocs
C3.ai Stock Overview | Amdocs Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
C3.ai2.61%13.51%24.90%-23.35%2.72%-43.29%
Amdocs0.13%1.19%-3.93%-10.23%0.43%-2.06%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
C3.ai-27.83%67.89%-83.56%-83.56%-83.56%-83.56%
Amdocs-6.59%4.33%40.98%40.81%175.50%212.95%

News Based Sentiment: C3.ai vs Amdocs

C3.ai

News based Sentiment: MIXED

October presented a complex picture for C3.ai, with both positive developments like the Agentic Process Automation launch and strategic partnerships, and significant negative factors including disappointing earnings, a CEO change, and a class action lawsuit. This mix of events makes it a crucial month for understanding the company's trajectory.

View C3.ai News Sentiment Analysis

Amdocs

News based Sentiment: MIXED

October presented a mixed bag for Amdocs, with a revenue decline offset by positive earnings, a strong focus on AI through key partnerships, and continued institutional investment. While the downgrade introduces caution, the overall narrative suggests a company actively adapting to industry changes and positioning itself for future growth, making it a significant month for investors to assess.

View Amdocs News Sentiment Analysis

Performance & Financial Health Analysis: C3.ai vs Amdocs

MetricAIDOX
Market Information
Market Cap i$3.49B$9.09B
Market Cap CategoryMid capMid cap
10 Day Avg. Volume i7,313,710959,580
90 Day Avg. Volume i6,099,750866,193
Last Close$19.66$82.43
52 Week Range$14.70 - $45.08$78.61 - $95.41
% from 52W High-56.39%-13.60%
All-Time High$183.90 (Dec 21, 2020)$99.75 (Jun 26, 2023)
% from All-Time High-89.31%-17.36%
Growth Metrics
Quarterly Revenue Growth0.26%-0.08%
Quarterly Earnings Growth0.26%0.10%
Financial Health
Profit Margin (TTM) i-0.74%0.12%
Operating Margin (TTM) i-0.82%0.18%
Return on Equity (TTM) i-0.34%0.16%
Debt to Equity (MRQ) i7.1923.65
Cash & Liquidity
Book Value per Share (MRQ)$6.26$31.85
Cash per Share (MRQ)$5.53$3.11
Operating Cash Flow (TTM) i$-41,407,000$737.18M
Levered Free Cash Flow (TTM) i$58.23M$563.54M
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: C3.ai vs Amdocs

MetricAIDOX
Price Ratios
P/E Ratio (TTM) i-11.6116.66
Forward P/E i-76.4711.71
PEG Ratio i-76.471.20
Price to Sales (TTM) i8.981.95
Price to Book (MRQ) i4.152.58
Market Capitalization
Market Capitalization i$3.49B$9.09B
Enterprise Value i$2.81B$9.59B
Enterprise Value Metrics
Enterprise to Revenue i7.232.06
Enterprise to EBITDA i-9.019.66
Risk & Other Metrics
Beta i1.980.52
Book Value per Share (MRQ) i$6.26$31.85

Financial Statements Comparison: C3.ai vs Amdocs

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)AIDOX
Revenue/Sales i$108.72M$1.14B
Cost of Goods Sold i$41.21M$711.15M
Gross Profit i$67.51M$433.29M
Research & Development i$58.39M$86.85M
Operating Income (EBIT) i$-88.97M$202.47M
EBITDA i$-85.57M$252.11M
Pre-Tax Income i$-79.59M$190.77M
Income Tax i$111,000$35.96M
Net Income (Profit) i$-79.70M$154.80M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)AIDOX
Cash & Equivalents i$164.36M$247.39M
Total Current Assets i$904.25M$1.56B
Total Current Liabilities i$131.88M$1.34B
Long-Term Debt iN/A$748.93M
Total Shareholders Equity i$838.30M$3.50B
Retained Earnings i$-1.38BN/A
Property, Plant & Equipment i$0$874.85M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)AIDOX
Operating Cash Flow i$8.89M$195.07M
Capital Expenditures i$-938,000$-15.96M
Free Cash Flow i$10.33M$156.49M
Debt Repayment iN/AN/A
Common Stock Repurchase iN/A$-135.24M

Short Interest & Institutional Ownership Analysis

MetricAIDOX
Shares Short i24.03M4.41M
Short Ratio i4.455.21
Short % of Float i0.23%0.05%
Average Daily Volume (10 Day) i7,313,710959,580
Average Daily Volume (90 Day) i6,099,750866,193
Shares Outstanding i132.74M112.89M
Float Shares i122.61M107.73M
% Held by Insiders i0.09%0.00%
% Held by Institutions i0.52%0.99%

Dividend Analysis & Yield Comparison: C3.ai vs Amdocs

MetricAIDOX
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A